Compounds > nonyl-4-hydroxyquinoline-n-oxide
Page last updated: 2024-09-03

nonyl-4-hydroxyquinoline-n-oxide and aripiprazole

nonyl-4-hydroxyquinoline-n-oxide has been researched along with aripiprazole in 1 studies

Compound Research Comparison

Studies
(nonyl-4-hydroxyquinoline-n-oxide)		Trials
(nonyl-4-hydroxyquinoline-n-oxide)		Recent Studies (post-2010)
(nonyl-4-hydroxyquinoline-n-oxide)		Studies
(aripiprazole)		Trials
(aripiprazole)		Recent Studies (post-2010) (aripiprazole)
27072,9895091,788

Protein Interaction Comparison

ProteinTaxonomynonyl-4-hydroxyquinoline-n-oxide (IC50)aripiprazole (IC50)
ATP-dependent translocase ABCB1Homo sapiens (human)0.78
D(2) dopamine receptorHomo sapiens (human)0.0158
5-hydroxytryptamine receptor 2AHomo sapiens (human)1.945
5-hydroxytryptamine receptor 2CHomo sapiens (human)1.38
Alpha-1A adrenergic receptorHomo sapiens (human)0.17
Histamine H1 receptorHomo sapiens (human)0.42
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)1.8572

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Handzlik, J; Jastrzębska-Więsek, M; Kieć-Kononowicz, K; Kucwaj-Brysz, K; Latacz, G; Lubelska, A; Partyka, A; Wesołowska, A1

Other Studies

1 other study(ies) available for nonyl-4-hydroxyquinoline-n-oxide and aripiprazole

ArticleYear
MF-8, a novel promising arylpiperazine-hydantoin based 5-HT
    Bioorganic & medicinal chemistry letters, 2018, 03-01, Volume: 28, Issue:5

    Topics: Dose-Response Relationship, Drug; Humans; Hydantoins; Molecular Structure; Piperazines; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship

2018